48-year-old haemophilia patient undergoes successful
2 min read
Fatehabad, November 27, 2024: The Orthopaedics Department at Fortis Hospital Mohali has successfully conducted Total Knee Replacement (TKR) surgery on a 48-year-old patient suffering from Type A Haemophilia recently.
Haemophilia is a rare disorder in which a patient’s blood does not clot normally as it lacks sufficient blood-clotting protein and a delay in treatment can prove to be fatal.
The case assumes significance as operating on a haemophilia patient is a challenging and a complex surgery. This is because the patient’s blood does not clot due to the absence of blood-clotting proteins.
If not managed properly, there is an increased risk of bleeding or bruising. While Type A Haemophilia (deficiency of Factor VIII) affects one out of 10,000 people, Type B Haemophilia (deficiency of Factor IX) occurs in one out of 40,000.
In this case, the 48-year-old patient had been experiencing acute pain and swelling in his joints along with excessive bleeding from minor injuries, thereby restricting his mobility. He approached Dr Gagan Deep Gupta, Consultant, Orthopaedics and Joint Replacement, at Fortis Hospital Mohali recently where medical examinations revealed that he was suffering from Type A Haemophilia.
The health condition is characterized by bleeding in the knee and ankle joints, muscles and even the brain. This causes synovial hyperplasia (inflammation in joints) and subsequent arthritis. Formation of subarticular cysts (fluid-filled sacs inside joints) is also common in such patients.
The team of doctors led by Dr Gupta conducted the Total Knee Replacement Surgery on the patient. Given his health condition, transfusion of Factor 8 at 50000 IU (international unit) was arranged. Owing to a huge hole in the patient’s tibia (shinbone), Dr Gupta used a long stem and rod, besides a gold implant for better mobility.
Discussing the case, Dr Gupta, said, “Following the surgery, the patient’s knee function and range of motion improved, and the pain reduced drastically. We administered him 2000 IU of Factor 8 twice a day for two weeks. He was discharged nine days after the surgery and is leading a normal life today.”
Dr Gupta, further, added, “Operating on a haemophilia patient is a difficult surgical procedure and requires advanced pre-operative planning. Treatment also includes injections of a clotting factor or an infusion of plasma. Fortis Mohali has the most advanced treatment options to treat haemophilia patients with excellent surgical outcomes.
